tiprankstipranks
NexgenRx Inc (TSE:NXG)
:NXG
Canadian Market

NexgenRx (NXG) Financial Statements

Compare
14 Followers

NexgenRx Financial Overview

NexgenRx's market cap is currently C$19.56M. The company's EPS TTM is C$0.003; its P/E ratio is 76.39; and it has a dividend yield of 3.64%. NexgenRx is scheduled to report earnings on April 9, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 10.82M-$ 9.81M$ 9.67M$ 8.37M
Operating Income$ -143.88K-$ 2.20M$ 2.16M$ 93.52K
EBITDA$ 1.15M-$ 3.40M$ 2.96M$ 815.97K
Net Income$ -331.97K-$ 4.02M$ 2.12M$ -207.94K
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 30.20M$ 25.75M$ 29.44M$ 25.24M$ 21.19M
Total Debt$ 461.88K$ 432.47K$ 401.76K$ 1.45M$ 4.10M
Net Debt$ -1.41M$ -1.33M$ -1.92M$ 643.66K$ 3.57M
Total Liabilities$ 22.48M$ 16.90M$ 19.72M$ 19.72M$ 19.35M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ 1.03M-$ 2.45M$ 2.65M$ 1.05M
Operating Cash Flow$ 1.28M$ 1.07M$ 3.82M$ 2.65M$ 1.05M
Investing Cash Flow
Financing Cash Flow
Currency in USD

NexgenRx Earnings and Revenue History

NexgenRx Debt to Assets

NexgenRx Cash Flow

NexgenRx Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis